Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-20-020622

Options or other derivatives

  • President acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Beigelman Leonid President 2020-12-01 Grant or award · Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc1.xml…